Cyclic Variation in Micronutrient Concentrations and Plasma Volume
1 other identifier
observational
47
1 country
1
Brief Summary
The overall goal of this study is to examine the influence of the menstrual cycle on micronutrient concentrations and plasma volume in healthy, reproductive-age women with regular cycles. The investigators aim to quantify changes in micronutrient biomarker concentrations (zinc, copper, iron, and vitamin A) and plasma volume across the menstrual cycle in healthy women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2018
CompletedStudy Start
First participant enrolled
January 17, 2018
CompletedFirst Posted
Study publicly available on registry
February 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2018
CompletedFebruary 1, 2019
January 1, 2019
10 months
January 16, 2018
January 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in serum zinc concentration across the menstrual cycle
Difference in mean serum zinc concentrations measured at three time points (day \~2, day\~12 and day\~21) within a single menstrual cycle will be examined.
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Change in serum copper concentration across the menstrual cycle
Difference in mean serum copper concentrations measured at three time points (day \~2, day\~12 and day\~21) within a single menstrual cycle will be examined.
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Change in serum retinol concentration across the menstrual cycle
Difference in mean serum retinol concentrations measured at three time points (day \~2, day\~12 and day\~21) within a single menstrual cycle will be examined.
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Change in plasma volume across the menstrual cycle
Difference in mean plasma volume measured at three time points (day \~2, day\~12 and day\~21) within a single menstrual cycle will be examined.
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Secondary Outcomes (2)
Change in serum ferritin concentration across the menstrual cycle
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Change in hemoglobin concentration across the menstrual cycle
~3 weeks (~day 2 to day ~21 of a 28 day menstrual cycle)
Eligibility Criteria
Eligible women in the State College area and surrounding towns within Centre County, Pennsylvania, United States.
You may qualify if:
- Female
- to 44 years of age
- General good health (does not have a known, ongoing health condition/medical issue that requires regular monitoring by a doctor or regular visits to the hospital)
- BMI 18.5-24.9 kg/m2
- Regular menstrual cycle (26-35 days)
- Non-smoker
- Non-pregnant
- If pregnant before, ≥12 months since last pregnancy
You may not qualify if:
- Known allergy to shellfish or iodine
- Blood pressure on the day of measurements is low or high (systolic blood pressure (SBP) \<90 or ≥130 mmHg and/or diastolic blood pressure (DBP) \<60 or ≥80 mmHg)
- Currently has low or high blood pressure (SBP \<90 or ≥130 mmHg and/or DBP \<60 or ≥80 mmHg), self-reported
- Current hypertension or previous hypertensive disorder in pregnancy (gestational hypertension or preeclampsia)
- Taking regular medication(s) (physician's prescribed medications for a health condition)
- Currently trying to conceive
- Currently breastfeeding
- Currently using hormonal birth control or used within last 3 months
- Used depot medroxyprogesterone acetate (DMPA) in the past 12 months
- Diagnosis of polycystic ovary syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alison Gernandlead
- Penn State Universitycollaborator
Study Sites (1)
The Pennsylvania State University
State College, Pennsylvania, 16802, United States
Biospecimen
Plasma, serum and urine samples
Study Officials
- PRINCIPAL INVESTIGATOR
Alison Gernand, PhD
The Pennsylvania State University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Nutritional Sciences
Study Record Dates
First Submitted
January 16, 2018
First Posted
February 6, 2018
Study Start
January 17, 2018
Primary Completion
November 20, 2018
Study Completion
November 20, 2018
Last Updated
February 1, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share